| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Saadi Ryan H. | 62% | -3.8% | $54,792,486 | -$211,200 | 124,528,376 | -0.38% | Ryan H. Saadi | 11 Dec 2025 |
As of 30 Sep 2025, 51 institutional investors reported holding 4,815,177 shares of Tevogen Bio Holdings Inc. - Common Stock, par value $0.0001 per share (TVGN). This represents 2.4% of the company’s total 200,852,220 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,065 | $684 | -$440 | $0.33 | 1 |
| 2025 Q3 | 4,815,177 | $3,781,892 | -$59,467 | $0.79 | 51 |
| 2025 Q2 | 4,835,189 | $6,044,298 | +$1,234,919 | $1.25 | 55 |
| 2025 Q1 | 3,851,004 | $4,160,133 | +$1,460,233 | $1.08 | 49 |
| 2024 Q4 | 2,414,123 | $2,488,565 | -$513,223 | $1.03 | 42 |
| 2024 Q3 | 5,647,671 | $2,081,020 | +$96,992 | $0.37 | 33 |
| 2024 Q2 | 3,698,099 | $2,674,095 | -$2,032,470 | $0.72 | 26 |
| 2024 Q1 | 6,779,132 | $30,688,068 | +$30,688,068 | $3.75 | 5 |